Mylan ramps up U.S. manufacturing of Hydroxychloroquine Sulfatetablets to meet potential COVID-19 patient needs
Mylan has restarted production of hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility in the U.S. to meet the potential for increased demand in treating COVID-19.
Technology Development Board under DST invites technology proposals for fighting COVID 19
The proposal may include technologically innovative solutions like low-cost masks, cost-effective scanning devices, technologies for sanitization of large areas as well as for contactless entry, rapid diagnostic kits and oxygenators, and ventilators.
CoSara Diagnostics to make 10,000 Covid-19 test kits daily
Mr Mohal Sarabhai, Director of CoSara, said in a statement: “Presently there are 52 government-approved testing facilities and delivering the kits to those is the first target,” in addition to pursuing 60 accredited private labs to conduct COVID-19 tests. “Overall, our target market will be private as well as government labs.”
BIRAC, DBT form COVID-19 Research Consortium and seek research proposals for intervention, control of COVID-19
To support the preparedness, readiness and response for COVID-19, project proposals are being solicited for developing intervention methods for control of COVID-19